HIGHLIGHTS
- who: Thomas Küstner and colleagues from the MIDASLab, Department of Radiology, University Hospital of Tübingen, Tubingen, Germany have published the paper: Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data, in the Journal: (JOURNAL)
- what: The aim of this pilot study was the development of a prognostic tool for the risk stratification of the treatment response and mortality based on and including a convolutional neural network (CNN) for metastasized-melanoma patients before systemic-treatment initiation. Experiments were conducted to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.